BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35187863)

  • 21. mTORC2/Rictor is essential for coelomocyte endocytosis in Apostichopus japonicus.
    Lv Z; Yue Z; Shao Y; Li C; Zhao X; Guo M
    Dev Comp Immunol; 2021 May; 118():104000. PubMed ID: 33444645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PPP1CA/YAP/GS/Gln/mTORC1 pathway activates retinal Müller cells during diabetic retinopathy.
    Guo Y; Cang X; Zhu L; Zhu M; Li A; Wang Z; Zhang Y; Wang X; Song E
    Exp Eye Res; 2021 Sep; 210():108703. PubMed ID: 34280391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential roles and activation of mammalian target of rapamycin complexes 1 and 2 during cell migration in prostate cancer cells.
    Venugopal SV; Caggia S; Gambrell-Sanders D; Khan SA
    Prostate; 2020 Apr; 80(5):412-423. PubMed ID: 31995655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-Asparaginase and inhibitors of glutamine synthetase disclose glutamine addiction of β-catenin-mutated human hepatocellular carcinoma cells.
    Tardito S; Chiu M; Uggeri J; Zerbini A; Da Ros F; Dall'Asta V; Missale G; Bussolati O
    Curr Cancer Drug Targets; 2011 Oct; 11(8):929-43. PubMed ID: 21834755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammalian target of rapamycin complex 2 (mTORC2) controls glycolytic gene expression by regulating Histone H3 Lysine 56 acetylation.
    Vadla R; Haldar D
    Cell Cycle; 2018; 17(1):110-123. PubMed ID: 29143563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mTORC2 Assembly Is Regulated by USP9X-Mediated Deubiquitination of RICTOR.
    Wrobel L; Siddiqi FH; Hill SM; Son SM; Karabiyik C; Kim H; Rubinsztein DC
    Cell Rep; 2020 Dec; 33(13):108564. PubMed ID: 33378666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implication of BAG5 downregulation in metabolic reprogramming of cisplatin-resistant ovarian cancer cells via mTORC2 signaling pathway.
    Wang JM; Gao Q; Zhang Q; Hao L; Jiang JY; Huyan LY; Liu BQ; Yan J; Li C; Wang HQ
    Biochim Biophys Acta Mol Cell Res; 2021 Aug; 1868(9):119076. PubMed ID: 34126157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of Combined Glypican-3 and Glutamine Synthetase in Differential Diagnosis of Hepatocellular Lesions.
    Wasfy RE; Shams Eldeen AA
    Asian Pac J Cancer Prev; 2015; 16(11):4769-75. PubMed ID: 26107238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
    Zhang X; Wang X; Xu T; Zhong S; Shen Z
    Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor.
    Masri J; Bernath A; Martin J; Jo OD; Vartanian R; Funk A; Gera J
    Cancer Res; 2007 Dec; 67(24):11712-20. PubMed ID: 18089801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukemia Cells Resistant to Glutamine Deprivation Express Glutamine Synthetase Protein.
    Yücel B; Ada S
    Turk J Haematol; 2022 Feb; 39(1):22-28. PubMed ID: 33882633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
    Julien LA; Carriere A; Moreau J; Roux PP
    Mol Cell Biol; 2010 Feb; 30(4):908-21. PubMed ID: 19995915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FOXO1 activates glutamine synthetase gene in mouse skeletal muscles through a region downstream of 3'-UTR: possible contribution to ammonia detoxification.
    Kamei Y; Hattori M; Hatazawa Y; Kasahara T; Kanou M; Kanai S; Yuan X; Suganami T; Lamers WH; Kitamura T; Ogawa Y
    Am J Physiol Endocrinol Metab; 2014 Sep; 307(6):E485-93. PubMed ID: 25074987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mTORC2 Signaling Is Necessary for Timely Liver Regeneration after Partial Hepatectomy.
    Xu M; Wang H; Wang J; Burhan D; Shang R; Wang P; Zhou Y; Li R; Liang B; Evert K; Utpatel K; Xu Z; Song X; Che L; Calvisi DF; Wang B; Chen X; Zeng Y; Chen X
    Am J Pathol; 2020 Apr; 190(4):817-829. PubMed ID: 32035060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PARP3, a new therapeutic target to alter Rictor/mTORC2 signaling and tumor progression in BRCA1-associated cancers.
    Beck C; Rodriguez-Vargas JM; Boehler C; Robert I; Heyer V; Hanini N; Gauthier LR; Tissier A; Schreiber V; Elofsson M; Reina San Martin B; Dantzer F
    Cell Death Differ; 2019 Sep; 26(9):1615-1630. PubMed ID: 30442946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of Rictor/mTORC2 in cardiomyocyte differentiation of mouse embryonic stem cells
    Zheng B; Wang J; Tang L; Tan C; Zhao Z; Xiao Y; Ge R; Zhu D
    Int J Biol Sci; 2017; 13(1):110-121. PubMed ID: 28123351
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Kim LC; Rhee CH; Chen J
    Mol Cancer Res; 2020 Nov; 18(11):1675-1684. PubMed ID: 32801163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2.
    Gupta M; Ansell SM; Novak AJ; Kumar S; Kaufmann SH; Witzig TE
    Blood; 2009 Oct; 114(14):2926-35. PubMed ID: 19641186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutamine Synthetase as a Therapeutic Target for Cancer Treatment.
    Kim GW; Lee DH; Jeon YH; Yoo J; Kim SY; Lee SW; Cho HY; Kwon SH
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two conserved glycine residues in mammalian and
    Pergolizzi B; Panuzzo C; Ali MS; Lo Iacono M; Levra Levron C; Ponzone L; Prelli M; Cilloni D; Calautti E; Bozzaro S; Bracco E
    J Cell Sci; 2019 Nov; 132(22):. PubMed ID: 31653780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.